Diaceutics PLC
DIUXFOTCHealthcare● Active
$2.00
+$0.00(+0.00%)
Market Cap$169258896
P/E Ratio—
52W High$2.51
52W Low$1.3672
Diaceutics PLC (DIUXF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · DIUXF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $38.43M | $32.16M | $23.70M | $19.50M | $13.94M |
| Cost of Revenue | $12.77M | $3.89M | $3.99M | $5.47M | $3.38M |
| Gross Profit | $25.66M | $28.27M | $19.71M | $14.04M | $10.57M |
| Gross Margin %(computed) | 66.78% | 87.91% | 83.15% | 71.97% | 75.78% |
| Operating Expenses | |||||
| R&D Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| G&A Expenses | $0.00M | $30.74M | $22.78M | $16.28M | $11.88M |
| Total Operating Expenses | $25.87M | $30.73M | $22.72M | $13.71M | $10.25M |
| Operating Income | ($0.21M) | ($2.46M) | ($3.02M) | $0.33M | $0.31M |
| Operating Margin %(computed) | -0.55% | -7.63% | -12.73% | 1.70% | 2.24% |
| Interest Income | $0.32M | $0.60M | $0.65M | $0.11M | $0.00M |
| Interest Expense | $0.06M | $0.05M | $0.07M | $0.12M | $0.09M |
| Income Before Tax | $0.30M | ($1.91M) | ($2.44M) | $0.48M | $0.29M |
| Income Tax Expense | $0.20M | ($0.20M) | ($0.69M) | ($0.25M) | ($0.27M) |
| Net Income | $0.10M | ($1.70M) | ($1.75M) | $0.72M | $0.56M |
| Net Margin %(computed) | 0.25% | -5.30% | -7.37% | 3.71% | 4.02% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.00 | $-0.02 | $-0.02 | $0.01 | $0.01 |
| Wtd Avg Shares | 84.58M | 84.31M | 84.23M | 84.15M | 83.94M |
| EBITDA | $5.60M | $2.77M | $2.40M | $3.61M | $2.11M |
| EBITDA Margin %(computed) | 14.57% | 8.62% | 10.13% | 18.50% | 15.15% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · GBP · M
Explore more Diaceutics PLC data
About Diaceutics PLC (DIUXF) Income Statement
Diaceutics PLC (DIUXF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, DIUXF reported revenue of $0.04B, gross profit of $0.03B (gross margin 66.78%), and net income of $0.00B — a net profit margin of 0.25%.
Frequently asked questions
DIUXF · 4 questionsDiaceutics PLC (DIUXF) reported revenue of $0.04B for 2025, up 19.5% year-over-year.
DIUXF revenueDIUXF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09